Diamyd Medical AB (publ) Capital Reinvestment Ratio
Diamyd Medical AB (publ) capital reinvestment ratio. Diamyd Medical AB (publ) (DMYD-B) has a Capital Reinvestment Ratio of 2026.00x as of November 2021, meaning it reinvests 2026% of its operating cash flow (Skr21.00K) in capital expenditures (Skr42.55 Million). See cash generation quality of Diamyd Medical AB (publ) to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Diamyd Medical AB (publ) (2010–2020)
Capital reinvestment ratio of Diamyd Medical AB (publ) from 2010 to 2020. This chart tracks Diamyd Medical AB (publ)'s Capital Reinvestment Ratio across 2 annual periods. See Diamyd Medical AB (publ) (DMYD-B) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Diamyd Medical AB (publ) Capital Reinvestment Ratio by Year (2010–2020)
Diamyd Medical AB (publ) capital reinvestment ratio by year from 2010 to 2020. For the full cash flow conversion analysis, see how efficiently does Diamyd Medical AB (publ) generate cash.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.12x | Skr16.88 Million | Skr1.98 Million | ▲ +3681.4% |
| 2010 | 0.00x | Skr225.77 Million | Skr700.00K | — |